Vimarsana
Biggest News Aggregation in the World

French Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from French Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In French Biotech Today - Breaking & Trending Today

OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2023 Earnings Call Transcript - Vimarsana News

OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing-by. Welcome to the OraSure Technologies Earnings Conference Call. At this time, participants are in listen-only mode.

Intellia Therapeutics (NASDAQ:NTLA) – Jeito Capital co-leads €75 million Series B financing in SparingVision - Press Release - Vimarsana News

Intellia Therapeutics (NASDAQ:NTLA) – Jeito Capital co-leads €75 million Series B financing in SparingVision - Press Release

- SparingVision is a French Biotech with the ambition of becoming a leader in genomics in ophthalmology. - Jeito Capital was a major investor in the S

OSE Immunotherapeutics Announces Collaboration with - Vimarsana News

OSE Immunotherapeutics Announces Collaboration with

OSE selected by Microsoft France to join the “Biotech Scaler Program” launched during “Viva Technology”, the European Startup and Tech event.This...

French COVID vaccine candidate Valneva reports better efficacy than AstraZeneca - Vimarsana News

French COVID vaccine candidate Valneva reports better efficacy than AstraZeneca

French Biotech company Valneva's COVID-19 vaccine candidate has reported positive Phase 3 trials with more efficacy and fewer side effects.

Top 10 Headlines: Gurmeet Ram Rahim gets life imprisonment; 3 dead in U'khand rains & more - Vimarsana News

Top 10 Headlines: Gurmeet Ram Rahim gets life imprisonment; 3 dead in U'khand rains & more

BJP condemns Pakistan-backed terrorism In J&K; Gurmeet Ram Rahim Singh & 4 others get life imprisonment in 2002 manager's death case. Read the latest news here